22nd National Convention of Society of Pharmacognosy & International Conference. AICTE Sponsored International Conference at Parul University.

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
PIPPHARMACON & IJPR 2018

PIPPHARMACON & IJPR 2018

Click to download
 

Article Detail

Label
Label
Lung Cancer in Lifelong Never Smokers-Short Review

Author: KIRTI SHARMA
Abstract: Occurrence of lung cancer in lifelong never smokers has been increased worldwide and most common cause of mortality was reported due to only lung cancer across the world. Lung cancer that occurs in never smokers is reported different from active smokers in terms of their molecular profile and response of chosen targeted therapies to combat lung cancer. Many genetic, hormonal and environmental factors were found responsible for the risk of lung cancer in never-smokers as per the available data on its clinical epidemiology that implicate its aetiology. Recently, the selected therapeutic approaches using EGFR-TK inhibitor, ALK inhibitor and HGFR or c-MET inhibitors were suggested to treat this disease as remarkable molecular targeted therapies which has been successfully proposed as more competent to suppress oncogenes in lifelong never smokers lung cancer patients.
Keyword: Lung cancer; Lifelong never smokers; EGFR-TK inhibitor; ALK inhibitor; c-MET inhibitors
Download: Request For Article
 










USER LOGIN


Username
Password
Login | Register
AICTE INTERNATIONAL CONFERENCE

AICTE Sponsored International Conference on Challenges, Opportunities and Newer Directions of Pharmacovigilance and Clinical Research in India

Download Brochure


For More Detail Visit www.pippharmacon.org
News & Events
22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit https://ncsp.ganpatuniversity.ac.in
Impact Factor for five years is 1.55 (2012 - 2016)
Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477
Impact Factor for five years is 1.3 (2010 - 2014)